Comparison of Changes in Cardiac Structure After Treatment in Secondary Hypertension
Yuji Yoshitomi(National Cerebral and Cardiovascular Center), Teruo Omae(National Cerebral and Cardiovascular Center), Atsushi Ashizawa(National Kidney Foundation), Fumiki Yoshiwara(National Kidney Foundation), Toshihide Suzuki(National Kidney Foundation), Morio Kuramochi(National Cerebral and Cardiovascular Center), Seiki Nagata(National Cerebral and Cardiovascular Center), Hitoshi Abe(National Kidney Foundation), Hiroaki Matsuoka(Social Welfare Department), Toshio Nishikimi(Kyoto University)
Cited by 44
Related Papers
Plasma Brain Natriuretic Peptide as a Prognostic Indicator in Patients With Primary Pulmonary Hypertension
|Circulation|2000|880
Plasma Brain Natriuretic Peptide Levels Increase in Proportion to the Extent of Right Ventricular Dysfunction in Pulmonary Hypertension
|Journal of the American College of Cardiology|1998|578
Erratum: The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2009)—Chapter 2
|Hypertension Research|2009|485
The role of natriuretic peptides in cardioprotection
|Cardiovascular Research|2005|483
Plasma levels of adrenomedullin, a newly identified hypotensive peptide, in patients with hypertension and renal failure.
|Journal of Clinical Investigation|1994|478